{"id":1156,"date":"2016-09-01T12:03:00","date_gmt":"2016-09-01T10:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2016\/leserbrief-familiaere-hyperlipoproteinaemie-und-unvertraeglichkeit-von-statinen"},"modified":"2016-09-01T12:03:00","modified_gmt":"2016-09-01T10:03:00","slug":"leserbrief-familiaere-hyperlipoproteinaemie-und-unvertraeglichkeit-von-statinen","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2016\/leserbrief-familiaere-hyperlipoproteinaemie-und-unvertraeglichkeit-von-statinen","title":{"rendered":"Leserbrief: Famili\u00e4re Hyperlipoprotein\u00e4mie und Unvertr\u00e4glichkeit von Statinen"},"content":{"rendered":"<p>Frage von Dr. L. aus S.: >> Eine 63-j\u00e4hrige sportliche, normalgewichtige Dame (Turnlehrerin) hat eine famili\u00e4re Hyperlipoprotein\u00e4mie (FH). Ohne Therapie liegen die Werte des Gesamtcholesterins um 500 mg\/dl und das LDL-C um 230 mg\/dl. Die Mutter hatte mit 70 Jahren einen Herzinfarkt, ansonsten ist die Familienanamnese hinsichtlich Koronarer Herzkrankheit (KHK) und Schlaganfall leer. Die asymptomatische [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frage von Dr. L. aus S.: >> Eine 63-j\u00e4hrige sportliche, normalgewichtige Dame (Turnlehrerin) hat eine famili\u00e4re Hyperlipoprotein\u00e4mie (FH). Ohne Therapie liegen die Werte des Gesamtcholesterins um 500 mg\/dl und das LDL-C um 230 mg\/dl. Die Mutter hatte mit 70 Jahren einen Herzinfarkt, ansonsten ist die Familienanamnese hinsichtlich Koronarer Herzkrankheit (KHK) und Schlaganfall leer. Die asymptomatische [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1274,451,449,455,453,456,1525,1526,1522,443],"class_list":["post-1156","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-cholesterin","tag-cholesterinsynthese-hemmer","tag-cse-hemmer","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-lipidsenker","tag-pcsk9","tag-pcsk9-antikoerper","tag-pcsk9-hemmer","tag-statine"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1156"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1156\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}